Tech Company Financing Transactions
ZetaRx Biosciences Funding Round
ZetaRx Biosciences closed a $750 thousand funding round on 12/31/2010. Backers included New England Partners and Oxford Bioscience Partners.
Transaction Overview
Company Name
Announced On
12/31/2010
Transaction Type
Venture Equity
Amount
$750,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
307 Westlake Ave. North 300
Seattle, WA 98109
USA
Seattle, WA 98109
USA
Phone
Email Address
Not Recorded
Overview
The company operates as a biotechnology company.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Executive Vice President
Cynthia Shumate
Browse more venture capital transactions:
Prev: 12/31/2010: M86 Security venture capital transaction
Next: 12/31/2010: Cardiac Dimensions venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries on this site are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs